NIFTY5023,346.4075.80 (0.33%)
Trader’s Lounge
Nuvama Partners
ISIN: INE858L01010PharmaceuticalsSmall Cap

CONCORD

Concord Drugs Limited
75.30-1.72(-2.23%)
BSE18-Sep-202604:01:22 PM
Day’s Open
79.98
Prev Day Close
77.02
Market Cap (in Cr)
99.21
ATP
75.55
Volume
3,751
Avg. 3month Vol
5,579
Lower Circuit Limit
60.24
Upper Circuit Limit
90.36
18 Sep 2026 04:01:22 PM
 
 
  • 75.30
  • 75.20
  • 1 Day Low/High
  • 79.98
  • 18-Sep-2026
  • 18-Sep-2026

Key Metrics

17-Sep-2026, 6:30 PM
Market Cap(₹ Cr)99
Face Value10.00
Beta 1Yr0.46
Shares OS (in cr)1.32
Earnings Per Share (TTM)1.67
Book Value Per Share (TTM)35.43
Dividend0.00

Historic Returns

18-Sep-2026, 10:31 AM
1 Week-5.25%NA
NA
1 Month+6.04%NA
NA
3 Month-1.09%NA
NA
6 Month-1.91%NA
NA
1 Year+12.39%-13.66%
26.05%
3 Year+115.57%+25.17%
90.40%
5 Year+176.33%+70.33%
106.00%
YTD-8.71%-9.12%
0.41%

Growth Metrics

Sales82.53%14.77%
EBITDA34.64%-0.44%
PAT410.00%1.98%
EPS288.37%-8.95%
Sales89.65%13.92%
EBITDA40.25%-0.78%
PAT448.65%5.39%
EPS323.08%-6.29%
*TTM: ending
JUN '26
*Annual: ending
MAR '26

Volume Analysis

20-Sep-2026, 2:59 PM
Today
3.75K
Yesterday
3.75K
2.60K
69.34 %
5 Day Avg
4.64K
3.31K
71.47 %
30 Day Avg
5.15K
4.15K
80.62 %
Total VolDelivery Volume
PE Ratio48.3687.79
P/Bv2.131.98
EV/EBITDA19.3823.34
EV/Sales1.311.35
MCAP/Sales1.151.18
PE Ratio48.3687.79
P/Bv2.131.98
EV/EBITDA19.3823.34
EV/Sales1.311.35
MCAP/Sales1.151.18
*TTM ending
JUN '26
*Annual: ending
MAR '26

Seasonality Analysis

Stock Scan
PeriodJanFebMarAprMayJunJulyAugSeptOctNovDec
Monthly Avg7.0
20227.0
2018
< -10
-10 to -5
-5 to 0
0 to 5
5 to 10
> 10

Technicals of Underlying

18-Sep-2026
Pivot  Level
R178.45
Pivot
76.83
S173.67
R281.61
S272.05
R383.23
S368.89
Technical Moving Average
1
7
 Bullish
Bearish 
5
77.60
3.05% abv LTP
10
78.40
4.12% abv LTP
12
78.40
4.12% abv LTP
20
78.00
3.59% abv LTP
26
77.60
3.05% abv LTP
50
76.60
1.73% abv LTP
100
76.40
1.46% abv LTP
200
74.20
1.46% blw LTP
5
78.20
3.85% abv LTP
10
79.00
4.91% abv LTP
20
79.20
5.18% abv LTP
30
76.80
1.99% abv LTP
50
74.50
1.06% blw LTP
100
77.00
2.26% abv LTP
150
77.20
2.52% abv LTP
200
78.00
3.59% abv LTP
Technical Indicators
3
3
 Bullish
Bearish 
Relative Strength Index44.08
RSI is mid-range
Money Flow Index29.38
MFI oversold
MACD0.84
MACD above Center
MACD Signal1.46
MACD above Center
Average True Range4.48
Average Directional Index49.39
Rate of Change (21)5.18
Rate of Change (125)4.28
Day Commodity Channel Index-100.70
William-97.87
-97.87 William
Stochastic Oscillator19.21
Stochastic Oscillator %D31.17
Stochastic RSI2.70
Stochastic RSI %D7.27
Awesome Oscillator2.20
Ultimate Oscillator41.23
Momentum Oscillator-5.01

Fundamentals

Financial Analysis
FY End
Trend
MAR '26
MAR '25
MAR '24
MAR '23
MAR '22
Net Sales
Growth %
78.74
+74.05%
45.24
+0.71%
44.92
-13.75%
52.08
-11.67%
58.96
NA
Total Expenditure
Growth %
% of Sales
74.22
+80.54%
+94.26%
41.11
+0.51%
+90.87%
40.90
-13.89%
+91.05%
47.50
-11.02%
+91.21%
53.38
NA
+90.54%
EBITDA(Operating Profit)
Growth %
Margin %
4.52
+9.44%
+5.74%
4.13
+2.74%
+9.13%
4.02
-12.23%
+8.95%
4.58
-17.92%
+8.79%
5.58
NA
+9.46%
Depreciation
1.37
1.43
1.56
1.63
1.76
EBIT
Growth %
Margin %
3.15
+16.67%
+4.00%
2.70
+9.76%
+5.97%
2.46
-16.61%
+5.48%
2.95
-22.77%
+5.66%
3.82
NA
+6.48%
Interest
% of EBIT
1.71
+54.29%
2.03
+75.19%
1.87
+76.02%
1.71
+57.97%
1.68
+43.98%
Other income
0.03
0.01
0.01
0.01
0.10
Minority int (before tax)
-
-
-
-
-
Profit Before Tax
Growth %
Margin %
1.47
+116.18%
+1.87%
0.68
+13.33%
+1.50%
0.60
-52.00%
+1.34%
1.25
-44.20%
+2.40%
2.24
NA
+3.80%
Total Tax
Tax Rate %
0.42
+28.57%
0.35
+51.47%
0.16
+26.67%
0.26
+20.80%
0.65
+29.02%
Profit After Tax
Growth %
Margin %
1.05
+218.18%
+1.33%
0.33
-25.00%
+0.73%
0.44
-55.56%
+0.98%
0.99
-37.74%
+1.90%
1.59
NA
+2.70%
Minority int (after tax)
-
-
-
-
-
Profit/Loss of Associate Company
-
-
-
-
-
PAT after Minority int & P/L Asso.Co.
1.05
0.33
0.44
0.99
1.59
Extraordinary Items
-
-
-
-
-
Adj Profit After Tax
Growth %
Margin %
1.05
+218.18%
+1.33%
0.33
-25.00%
+0.73%
0.44
-55.56%
+0.98%
0.99
-37.74%
+1.90%
1.59
NA
+2.70%
EPS (Adj)
0.80
0.34
0.47
1.06
1.82
Dividend Per Share Adj.(Rs)
-
-
-
-
-
Book Value (Adj) (Unit Curr.)
35.43
34.11
33.82
33.43
32.44
FY End
Trend
MAR '26
MAR '25
MAR '24
MAR '23
MAR '22
Liabilities
Total Shareholders Funds
48.52
34.11
33.82
31.70
28.36
Minority int
-
-
-
-
-
Total Debt
14.51
19.24
17.52
16.96
16.43
Policy Holders Fund
-
-
-
-
-
Other Liabilities
2.87
2.91
2.86
2.47
2.09
Total Liabilities
65.90
56.26
54.20
51.13
46.88
Assets
Net Block
11.58
12.21
11.67
12.92
13.97
Lease Adjustment
-
-
-
-
-
Capital Work in Progress
2.43
2.00
1.63
0.92
0.55
Investments
0.78
0.80
0.84
0.89
-
Loans
-
-
-
-
-
Inventories
25.52
25.27
22.92
20.06
17.49
Sundry Debtors
24.38
13.60
12.73
15.81
22.86
Cash and Bank
0.75
0.23
0.18
0.10
0.07
Loans and Advances
2.67
1.66
1.69
7.48
1.48
Total Current Assets
53.32
40.76
37.52
43.45
41.90
Less : Current Liabilities and Provisions
Current Liabilities
7.95
8.05
3.91
6.18
8.24
Provisions
0.41
0.21
0.22
0.38
0.67
Total Current Liabilities
8.36
8.26
4.13
6.56
8.91
Net Current Assets
44.96
32.50
33.39
36.89
32.99
Miscellaneous Exp. not written off
-
-
-
-
-
Deferred Tax Assets
-
-
-
-
-
Deferred Tax Liability
0.63
0.63
0.47
0.54
0.66
Net Deferred Tax
-0.63
-0.63
-0.47
-0.54
-0.66
Other Assets
6.78
9.38
7.14
0.05
0.03
Total Assets
65.90
56.26
54.20
51.13
46.88
FY End
Trend
MAR '26MAR '25MAR '24MAR '23MAR '22
Cash and Cash Equivalents at Beginning of the year
-
-
-
-
-
Net Cash from Operating Activities
-6
4
1
2
1
Net Cash Used in Investing Activities
-1
-2
-1
-2
-2
Net Cash Used in Financing Activities
7
-1
-
1
2
Net inc/(Dec) in Cash and Cash Equivalent
-
-
-
-
-
Cash and Cash Equivalents at End of the year
-
-
-
-
-
Other Bank Balance
-
-
-
-
-
Total Cash & Bank
1
-
-
-
-

FY End
Sales Growth
EBITDA Growth
EBIT Growth
Profit Before Tax Growth
Profit After Tax Growth
Adj Profit After Tax Growth
Sales 3 yr CAGR
EBITDA 3 yr CAGR
Adj Profit After Tax 3 yr CAGR
MAR '26
+74.05%
+9.44%
+16.67%
+116.18%
+218.18%
+218.18%
+14.77%
-0.44%
+1.98%
MAR '25
+0.71%
+2.74%
+9.76%
+13.33%
-25.00%
-25.00%
-8.45%
-9.54%
-40.79%
MAR '24
-13.75%
-12.23%
-16.61%
-52.00%
-55.56%
-55.56%
-
-
-
MAR '23
-11.67%
-17.92%
-22.77%
-44.20%
-37.74%
-37.74%
-
-
-
MAR '22
NA
NA
NA
NA
NA
NA
-
-
-

FY End
EBITDA
EBIT
Profit Before Tax
Profit After Tax
Adj Profit After Tax
MAR '26
+5.74%
+4.00%
+1.87%
+1.33%
+1.33%
MAR '25
+9.13%
+5.97%
+1.50%
+0.73%
+0.73%
MAR '24
+8.95%
+5.48%
+1.34%
+0.98%
+0.98%
MAR '23
+8.79%
+5.66%
+2.40%
+1.90%
+1.90%
MAR '22
+9.46%
+6.48%
+3.80%
+2.70%
+2.70%

FY End
Debt Equity Ratio
Long Term Debt Equity Ratio
Interest Coverage Ratio
MAR '26
0.41
0.05
+54.29%
MAR '25
0.54
0.04
+75.19%
MAR '24
0.53
0.04
+76.02%
MAR '23
0.56
0.06
+57.97%
MAR '22
0.58
0.06
+43.98%

FY End
Return on Capital Employed
Return on Networth
MAR '26
+5.22%
+2.57%
MAR '25
+4.94%
+1.00%
MAR '24
+4.75%
+1.43%
MAR '23
+6.04%
+3.30%
MAR '22
+8.36%
+5.61%

FY End
Fixed Asset Turnover
Inventory Turnover
Debtors Turnover
MAR '26
1.95
3.10
4.15
MAR '25
1.16
1.88
3.44
MAR '24
1.19
2.09
3.15
MAR '23
1.39
2.77
2.69
MAR '22
1.59
3.37
2.58

FY END
Price to Earnings (PE)
Price to Book Value (PBV)
EV to EBITDA
EV to Sales
TTM
48.36
2.13
19.38
1.31
2026
87.79
1.98
23.34
1.35
2025
91.41
0.91
12.08
1.11
2024
74.83
1.04
12.96
1.17
2023
25.90
0.82
9.26
0.78

FY End
EPS
DPS
Book Value
Face Value
MAR '26
0.80
-
35.43
10.00
MAR '25
0.34
-
34.11
10.00
MAR '24
0.47
-
33.82
10.00
MAR '23
1.06
-
33.43
10.00
MAR '22
1.82
-
32.44
10.00
Download
FY End20262025202420232022
Annual Reports
Investor Presentation
Earnings Call

SWOT in Analysis

  • Companies with rising net profit margins - quarterly as well as TTM basis
  • Companies with high TTM EPS Growth
  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Companies with Low Debt
  • Increasing profits every quarter for the past 4 quarters
  • Book Value per share Improving for last 2 years
  • Companies with Zero Promoter Pledge
  • Promoter decreasing their shareholding
  • Promoter holding decreased by more than -2% QoQ
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income
  • RSI indicating price weakness
Data not available
Data not available

News/ Corporate Events

Live News
View All
No Data available

Deals

Reported on
Client Name/Category
Mode
Average Price
ActionNo of shares (% of total)
02-Dec-25
S Koni Reddy
NA
5,00,000  (3.80%)
02-Dec-25
S Nagi Reddy
NA
5,00,000  (3.80%)
02-Dec-25
S Manoj Kumar Reddy
NA
5,00,000  (3.80%)
24-Nov-25
S Koni Reddy
9.07
5,50,000  (4.17%)
24-Nov-25
S Manoj Kumar reddy
36.30
1,50,000  (1.14%)
24-Nov-25
S Nagi Reddy
36.30
2,00,000  (1.52%)
Reported on
Client Name/Category
Average Price
ActionNo of shares (% of total)
04-Jul-25
PRADEEP KUMAR JAIN
54.48
69,944  (0.53%)
03-Jul-25
GANGA DEVI LOYA
53.25
51,655  (0.39%)
03-Jul-25
PRADEEP KUMAR JAIN
53.21
1,49,164  (1.13%)
03-Jul-25
GANGA DEVI LOYA
53.90
11,555  (0.09%)
30-Jun-25
GANGA DEVI LOYA
38.66
51,571  (0.39%)
15-Jan-24
LAKSHMI PRASANNA PALLETI
44.63
51,994  (0.39%)

 About Company

About  Concord Drugs Limited
Key Brands
  • Concord Drugs
Industry
Pharm-Ind-BD&For
Contact Information
Tel. No.
91-40-24036379
Email
Fax No.
null
Company website
http://www.concorddrugs.in
Details
BSE
CONCORD
NSE
CONCORD
Series
EQ
ISIN
INE858L01010
Executive Summary
Chairman / Executive Director / M D / Promoter
S Nagi Reddy
ED / WTD / CFO / Promoter
Koni Reddy
WTD & Executive Director
S. Manoj Kumar Reddy
Independent Non Exe. Director
K Ramchandra Reddy
Independent Non Exe. Director
Summela Kasu

Understanding Sections

Insider Trading and SAST
Back to Insider Trading and SAST
Insider trading refers to trading in a shares by someone who has access to non-public, material information about that stock that can affect the stock’s price. SAST (Substantial Acquisition of Shares and Takeovers) refers to trades which involve high volume resulting in the acquirer acquiring substantial number of shares and voting rights in the target company (Substantial Acquisition of Shares) or taking over the control of the target company (Takeovers)
Seasonality Analysis
Back to Seasonality Analysis
Seasonality Analysis shows how a stock / index performs during a month across years based on various parameters like average returns, number of positive years, number of negative years etc. For indices you can also check the stocks which perform better/worse during a month across the years.
Feedback